investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

How do genome alterations cause human lung cancer?

Matthew L. Meyerson

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Matthew L. Meyerson

Broad Institute

Cambridge, United States

Dana-Farber Cancer Institute

Boston, United States

Related projects

Shioko Kimura

Role of Novel Cytokine-like Molecules Secretoglobin (SCGB) 3A1 and 3A2 in Lung

Trachea, bronchus and lung

Pathology

Gregory J Hannon

Cold Spring Harbor Laboratory Cancer Research Center

Trachea, bronchus and lung

Uwe Rix

Harnessing beneficial off-target effects of kinase inhibitors in lung cancer

Trachea, bronchus and lung

Pathology

Bingliang Fang

Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing

Trachea, bronchus and lung

Susan Bates

Translational Studies of the Histone Deacetylase Inhibitor Romidepsin

Trachea, bronchus and lung

Kwok Kin Wong

Therapeutic strategies for specific subsets of KRAS mutant lung cancers

Trachea, bronchus and lung

William Stetler-Stevenson

The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis

Trachea, bronchus and lung

Carlo M Croce

MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment

Trachea, bronchus and lung

Jeffrey Mackeigan

Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer

Trachea, bronchus and lung

Pathology